Home > Insider Trading > Filing (0000886163-13-000102)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886163	Ligand Pharmaceuticals Inc	LGND	Pharmaceutical Preparations (2834)	770160744

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1208906	L John Higgins	11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-10-18	10,000	$55.00	106,581	No	4	S	Direct
Common Stock	Acquisiton	2013-10-22	5,850	$21.00	112,431	No	4	M	Direct
Common Stock	Acquisiton	2013-10-22	4,668	$10.05	117,099	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-10-22	4,668	$0.00	4,668	$10.05
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-10-22	5,850	$0.00	5,850	$21.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,675		2021-02-17	No	4	M	Direct
37,483		2018-02-23	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 11, 2013, in accordance with Rule 10b5-1.
Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/17/11.
Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 2/23/08.